NCT03401697View on ClinicalTrials.gov

Eliminating Hepatitis C Virus

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

January 23, 2018

Primary Completion Date

March 1, 2021

Study Completion Date

March 1, 2021

Conditions
Hepatitis CHIVType2 Diabetes
Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT03401697 - Eliminating Hepatitis C Virus | Biotech Hunter | Biotech Hunter